{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:10:50Z","timestamp":1778825450058,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07359"],"award-info":[{"award-number":["JP23K07359"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["AMED JP24fk0310518"],"award-info":[{"award-number":["AMED JP24fk0310518"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101764","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:23:58Z","timestamp":1733228638000},"page":"101764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation"],"prefix":"10.1016","volume":"30","author":[{"given":"Takanori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-4864","authenticated-orcid":false,"given":"Akihiro","family":"Tamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Sagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Kawamra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuzo","family":"Kozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aohep.2024.101764_bib0001","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.aohep.2024.101764_bib0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-016-1168-2","article-title":"Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies","volume":"51","author":"Mochida","year":"2016","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101764_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101764_bib0004","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101764_bib0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2004.05.161","article-title":"Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy","volume":"22","author":"Yeo","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101764_bib0006","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.aohep.2024.101764_bib0007","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/hepr.13504","article-title":"Guidelines for the management of Hepatitis B virus infection: 2019 update","volume":"50","year":"2020","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.aohep.2024.101764_bib0008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2021.02.017","article-title":"Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation","volume":"75","author":"Inoue","year":"2021","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2024.101764_bib0009","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00535-022-01872-w","article-title":"Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation","volume":"57","author":"Suzuki","year":"2022","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101764_bib0010","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00535-016-1244-7","article-title":"Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody","volume":"52","author":"Matsumoto","year":"2017","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101764_bib0011","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00535-023-02046-y","article-title":"Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance","volume":"59","author":"Suzuki","year":"2024","journal-title":"J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101764_bib0012","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/hepr.13761","article-title":"Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay","volume":"52","author":"Hagiwara","year":"2022","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.aohep.2024.101764_bib0013","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1002\/jmv.26526","article-title":"Outcome of nucleos(t)ide analog intervention in patients with preventive or on-demand therapy for hepatitis B virus reactivation","volume":"93","author":"Tamori","year":"2021","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101764_bib0014","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.aohep.2024.101764_bib0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2024.101764_bib0016","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/JCM.00366-07","article-title":"Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection","volume":"45","author":"Wong","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101764_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.21339","article-title":"Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients","volume":"81","author":"Suzuki","year":"2009","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101764_bib0018","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.06.006","article-title":"Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report","volume":"55","author":"Chan","year":"2011","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2024.101764_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbmt.2008.08.007","article-title":"HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection","volume":"14","author":"Onozawa","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.aohep.2024.101764_bib0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41409-020-0833-5","article-title":"A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation","volume":"55","author":"Nishikawa","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.aohep.2024.101764_bib0021","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","article-title":"Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy","volume":"102","author":"Westhoff","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.aohep.2024.101764_bib0022","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jhep.2010.04.034","article-title":"HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus","volume":"53","author":"Power","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101764_bib0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcv.2006.10.006","article-title":"Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient","volume":"38","author":"Awerkiew","year":"2007","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101764_bib0024","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:37:30Z","timestamp":1778823450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124005477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124005477"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101764","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101764"}}